Browse
Submit Data
Databases
API
Help

Dataset Information

9 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-Chloro-9-isopropyl-N,N-dimethyl-9H-purin-6-amine.

ABSTRACT: In the title compound, C(10)H(14)ClN(5), the imidazole and pyrimidine rings are essentially planar [maximum deviation = 0.0013?(14) and 0.0207?(13)?Å, respectively]. In the crystal, the mol-ecules are linked by weak C-H?N inter-actions into chains parallel to the c axis and the crystal packing is stabilized by additional weak C-H?N and C-H?Cl inter-actions.

SUBMITTER: Rouchal M

PROVIDER: S-EPMC2979083 | biostudies-other | 2010

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

2-Chloro-9-isopropyl-N,N-dimethyl-9H-purin-6-amine.

Rouchal Michal M Nečas Marek M Vícha Robert R

Acta crystallographica. Section E, Structure reports online 20100402 Pt 5

In the title compound, C(10)H(14)ClN(5), the imidazole and pyrimidine rings are essentially planar [maximum deviation = 0.0013 (14) and 0.0207 (13) Å, respectively]. In the crystal, the mol-ecules are linked by weak C-H⋯N inter-actions into chains parallel to the c axis and the crystal packing is stabilized by additional weak C-H⋯N and C-H⋯Cl inter-actions. ...[more]

PMID: 21579080

Similar Datasets

N-Benzyl-9-isopropyl-9H-purin-6-amine.

Project description:The asymmetric unit of the title compound, C15H17N5, consists of two mol-ecules in which the dihedral angles between the best planes of the purine ring system (r.m.s. deviations = 0.0060 and 0.0190?Å) and the benzene ring are 89.21?(3) and 82.14?(4)°. The mol-ecules within the asymmetric unit are linked into dimers by pairs of N-H?N hydrogen bonds. Weak C-H?? contacts and ?-? inter-actions [centroid-centroid = 3.3071?(1)?Å] further connect the mol-ecules into a three-dimensional network.

| S-EPMC3685095 | biostudies-literature

2-Chloro-N-ethyl-9-isopropyl-9H-purin-6-amine.

Project description:In the title compound, C(10)H(14)ClN(5), the purine ring system is essentially planar, with an r.m.s. deviation from the least-squares plane defined by the nine constituent atoms of 0.0063?(11)?Å. In the crystal, mol-ecules are linked by weak N-H?N and C-H?? inter-actions.

| S-EPMC3435794 | biostudies-other

4-(1-Adamantylmeth-yl)-N-(2-chloro-9-isopropyl-9H-purin-6-yl)aniline.

Project description:The asymmetric unit of the title compound, C(25)H(30)ClN(5), consists of two mol-ecules with slightly different geometrical parameters. The dihedral angles between the purine and benzene rings are 39.54?(5) and 23.69?(5)° in the two mol-ecules. The adamantane cages consist of three fused cyclo-hexane rings in classical chair conformations, with C-C-C angles in the range 108?(2)-111?(2)°. In the crystal, mol-ecules are linked into dimers via two N-H?N hydrogen bonds.

| S-EPMC2969425 | biostudies-literature

9-Benzyl-6-benzyl-sulfanyl-9H-purin-2-amine.

Project description:In the title compound, C19H17N5S, the dihedral angles between the purine ring system (r.m.s. deviation = 0.009?Å) and the S-bound and methyl-ene-bound phenyl rings are 74.67?(8) and 71.28?(7)°, respectively. In the crystal, inversion dimers linked by pairs of N-H?N hydrogen bonds generate R 2 (2)(8) loops. C-H?N inter-actions link the dimers into (100) sheets.

| S-EPMC3998501 | biostudies-literature

(1-Adamant-yl){4-[(2-chloro-9-isopropyl-9H-purin-6-yl)aminometh-yl]phen-yl}methanone trichloro-methane solvate.

Project description:In the title compound, C(26)H(30)ClN(5)O·CHCl(3), the purine mol-ecule consists of essentially planar benzene and purine ring systems [maximum deviation 0.010?(4)?Å for both ring systems] forming a dihedral angle of 85.52?(9)°. Inter-molecular N-H?N hydrogen bonds link adjacent mol-ecules into centrosymmetric dimers. The structure also contains inter-molecular C-H?O and C-H?N inter-actions. The benzene rings form offset face-to-face ?-? stacking inter-actions with an inter-planar distance of 3.541?(4)?Å and a centroid-to-centroid distance of 4.022?(4)?Å.

| S-EPMC2969555 | biostudies-literature

N-(2-Meth-oxy-benz-yl)-9-(oxolan-2-yl)-9H-purin-6-amine.

Project description:The title compound, C17H19N5O2, features an almost planar purine skeleton (r.m.s. deviation = 0.009?Å) substituted by a tetra-hydro-furan ring, which adopts an envelope conformation. The purine and benzene rings subtend a dihedral angle of 66.70?(3)°. In the crystal, pairs of N-H?N hydrogen bonds connect adjacent mol-ecules into inversion dimers. C-H?N, C-H?O, C-H?? and ?-? inter-actions [pyrimidine ring centroid-centroid distance = 3.3909?(1)?Å] connect the dimers into a three-dimensional architecture.

| S-EPMC3629632 | biostudies-literature

2-(1-Adamant-yl)-1-{4-[(2-chloro-9-isopropyl-9H-purin-6-yl)amino-meth-yl]phen-yl}ethanone.

Project description:The structure of the title compound, C(27)H(32)ClN(5)O, consists of two crystallographically independent conformers differing slightly in all geometric parameters. Both contain nearly planar purine and benzene ring systems [maximum deviations of 0.046?(3) and 0.005?(2)?Å, respectively], the dihedral angles between them being 76.44?(6) and 82.39?(6)°, and an adamantane cage consisting of three fused cyclo-hexane rings in almost ideal chair conformations, with C-C-C angles in the range 108.7?(2)-110.6?(2)°. The carbonyl plane and the benzene ring are almost coplanar [dihedral angles of 6.43?(9) and 0.64?(8)° in the two conformers]. The crystal structure is stabilized by inter-molecular N-H?N inter-actions that link adjacent mol-ecules into dimers and by some non-bonding contacts of the C-H?Cl type.

| S-EPMC2968337 | biostudies-other

2-Chloro-6-[(2,4-dimeth-oxy-benz-yl)amino]-9-isopropyl-9H-purine.

Project description:In the title compound, C17H20ClN5O2, the benzene ring and the purine ring system make a dihedral angle of 78.56?(4)°. In the crystal, mol-ecules are linked by pairs of N-H?N hydrogen bonds, forming inversion dimers. C-H?O and C-H?Cl contacts further link the mol-ecules, forming a three-dimensional network.

| S-EPMC3588409 | biostudies-literature

Discovery of Novel Bruton's Tyrosine Kinase (BTK) Inhibitors Bearing a N,9-Diphenyl-9H-purin-2-amine Scaffold.

Project description:Based on the pyrimidine skeleton of EGFRT790M inhibitors, a series of N,9-diphenyl-9H-purin-2-amine derivatives were identified as effective BTK inhibitors. Among these compounds, inhibitors 10d, 10i, and 10j, possessing IC50 values of 0.5, 0.5, and 0.4 nM, displayed anti-BTK kinase activity that was as potent as the reference compounds. In particular, compound 10j suppressed the proliferation of two typical B-cell leukemia cell lines expressing high levels of BTK with concentrations of 7.75 and 12.6 ?M. The activity of the subject compound as determined by the CCK-8 method and apoptosis analysis validated that inhibitor 10j is slightly more potent than AVL-292 and ibrutinib. The results of these experimental explorations suggested that 10j could serve as a valuable molecule for control of leukemia pending further developments.

| S-EPMC5150693 | biostudies-literature

(E)-(4-Chloro-benzyl-idene){[(1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octa-hydro-1-phenanthryl]-methyl}amine.

Project description:The title compound, C(27)H(34)ClN, has been synthesized from 4-chloro-benzaldehyde and dehydro-abietylamine. There are two unique mol-ecules in the unit cell. Each mol-ecule has three chiral centres, which exhibit R, S and R absolute configurations. The two cyclo-hexane rings form a trans ring junction with classical chair and half-chair conformations.

| S-EPMC2977794 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data